NEWwbztv-small wbz-am-small 985-small mytv38web2

Sanofi-Aventis

boston skyline - thinkstock

Sanofi-Aventis Sees A Bright Future In Boston-Cambridge

Sanofi CEO Chris Viehbacher says research departments have been consolidated here to be near universities.

04/30/2012

(AP Graphic

It’s A Done Deal For Genzyme

After nine months of denials, rejection, bickering and finally, discussion, French pharmaceutical company Sanofi-Aventis of Paris has signed a deal to buy Genzyme of Cambridge for $20.1 billion plus other milestone payments in the future.

02/16/2011

Genzyme headquarters

Genzyme Sold To Sanofi-Aventis In $20 Billion Deal

Cambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.

02/16/2011

Genzyme headquarters

Genzyme Rejects Latest Sanofi Offer

Sanofi-Aventis extended its unsolicited $18.5 billion takeover offer for Cambridge biotech company Genzyme Corp. Monday.

12/13/2010

Talk of possible Genzyme sale heating up

The Cambridge biotech company is being pursued by French drug company Sanofi-Aventis.  WBZ New England Business Editor Anthony Silva talked with Ken Bredemeier,  senior health care reporter at The Deal.

08/03/2010